Li Liu
- Molecular Biology top 5%
- Oncology top 1%
- Epidemiology top 1%
- Surgery top 2%
- Physiology top 1%
- Topics
- Liver Disease Diagnosis and Treatment (64 papers)Renal cell carcinoma treatment (45 papers)Cancer Immunotherapy and Biomarkers (36 papers)
- Cited by
- OncologyHepatologyPhysiology
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Li Liu
474 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Molecular Biology 2.5k
- Oncology 1.7k
- Epidemiology 1.7k
- Surgery 1.5k
- Physiology 1.4k
Countries citing papers authored by Li Liu
This map shows the geographic impact of Li Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Liu more than expected).
Fields of papers citing papers by Li Liu
This network shows the impact of papers produced by Li Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Liu. The network helps show where Li Liu may publish in the future.
Co-authorship network of co-authors of Li Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Li Liu. A scholar is included among the top collaborators of Li Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Liu. Li Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 9 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 25 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 0 | |
| 13 | 0 | |
| 14 | 1 | |
| 15 | 0 | |
| 16 | 5 | |
| 17 | 4 | |
| 18 | 9 | |
| 19 | 27 | |
| 20 | 124 |
About Li Liu
Li Liu is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Oncology, having authored 507 papers that have together received 9.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (64 papers), Renal cell carcinoma treatment (45 papers) and Cancer Immunotherapy and Biomarkers (36 papers). The work is most often cited by research in Oncology (1.7k citations), Hepatology (474 citations) and Physiology (1.4k citations). Li Liu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Kun Song, Kaijun Niu, Jiejie Xu, Jianming Guo, Shaomei Sun, Ming Zhou, Yeqing Gu, Takumi Kamura, Dewan Haque and Shigeo Sato. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.